Astec Lifesciences IPO subscribed fully

Published on Wed, Nov 04, 2009 at 10:29 |  Source : Moneycontrol.com

Updated at Thu, Nov 05, 2009 at 10:28  

Like this story, share it with millions of investors on M3
0
0
Share on Tumblr
Astec Lifesciences IPO subscribed fully

The initial public offering (IPO) of Astec Lifesciences closed for subscription. It has received mild response on the last day and was subscribed 1.56 times, as per the data available on the NSE website.

The non-institutional investors' portion got subscribed 3 times; retail segment was subscribed 2.36 times and QIB 0.61 times.

The issue was of 75,00,000 equity shares of Rs 10 each for cash at a price of Rs 77-82 per equity share, aggregating Rs 57.75-61.50 crore.

The company is engaged in the manufacture and sale of intermediates, active ingredients and formulations in the off patent-proprietary category with a focus on agrochemical and pharmaceutical sector.

It carries out manufacturing activities at two locations in Maharashtra, India comprising of three units viz. one unit at Dombivli, Maharashtra and two units at Mahad, Maharashtra.

The issue comprises a reservation of 1,00,000 equity shares for subscription by eligible employees at the issue price, and net issue of 74,00,000 equity shares. The issue constitutes 44.30% of the fully diluted post issue paid-up capital of the company.

The money raised via issue will be used for expansion of existing manufacturing facilities at Mahad, Maharashtra (at cost of Rs 31.24 crore); expansion of existing research and development facility at Dombivli, Maharashtra (at Rs 2.46 crore); meeting registration expenses (at Rs 3.69 crore) and meeting long-term working capital requirements (at Rs 11 crore).

The equity shares are proposed to be listed on the Bombay Stock Exchange and National Stock Exchange of India.

Almondz Global Securities Limited is the book running lead manager and IDBI Capital Market Services Ltd is the co-book running lead manager to the issue. Bigshare Services Private Ltd is the registrar to the issue.

  

More on Moneycontrol

Trending News

Business News

Apple rushing to finalize apps for iPad 3 announcement
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com